The 35 references in paper A. Chuchalin G., А. Чучалин Г. (2015) “Пневмония: актуальная проблема медицины ХХΙ века // Pneumonia as an actual medical problem of the 21th century” / spz:neicon:pulmonology:y:2015:i:2:p:133-142

1
Rozenbaum M.H., Pechlivanoglou P., van der Werf T.S. et al. The role of Streptococcus pneumoniae in communityacquired pneumonia among adults: a meta-analysis. Eur. J. Clin. Microb. Infect. Dis. 2013, 32: 305–316.
(check this in PDF content)
2
Sinclair A., Xie X., Teltscher M., Dendukuri N. Systematic review and meta-analysis of urine pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J. Clin. Microbiol. 2013; 51 (7): 2303–2310.
(check this in PDF content)
3
Horita N., Miyazawa N., Kojima R.et al. Sensetivity and specificity of the S. pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology. 2013; 18: 1177–1183.
(check this in PDF content)
4
Biondi E., McCulloh R., Alverson B. et al. Treatment of Mycoplasma pneumoniae: a systematic review. Pediatrics. 2014; 133 (6): 1081–1090.
(check this in PDF content)
5
Chalmers J.D., Rother C., Salih W., Ewig S. Healthcareassociated pneumonia does not accurately identify potentially resistant pathogen: a meta-analysis.Clin. Infect. Dis. 2014, 58: 330–339.
(check this in PDF content)
6
Troltino A.S., Porhomayon J., El-Solh A.A. Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis. Lung. 2013; 191: 229–237.
(check this in PDF content)
7
Phung D.T., Wang Z., Rutherford S. et al. Body mass index and risk of pneumonia: a systematic review meta-analysis. Obesity Rev.2013; 14: 839–857.
(check this in PDF content)
8
Nie W., Zhang Y., Jee S.H. et al. Obesity survival paradox in pneumonia: a meta-analysis.BCM Med.2014; 12: 61.
(check this in PDF content)
9
Mannu G.S., Loke Y.K., Curtain J.P. et al. Prognosis of multi-lobar pneumonia in community-acquired pneumoniae: a meta-analysis. Eur. J. Inter. Med.2013; 24 (8): 857–863.
(check this in PDF content)
10
Li L., Nie W., Li W. et al. Associations between TNF-α polymorphisms and pneumonia: a meta-analysis. PloS One. 2013; 8 (4): e61039.
(check this in PDF content)
11
Loke Y.K., Kwok C.S., Wong J.M. et al. Chronic obstructive pulmonary disease and mortality from pneumonia: a metaanalysis. Int. J. Clin. Pract. 2013; 67 (5): 477–487.
(check this in PDF content)
12
Salih W., Schembri S., Chalmers J.D. Simplification of the IDSA / ATS criteria for severe CAP using meta-analysis. Eur. Respir. J. 2014; 43 (3): 842–851.
(check this in PDF content)
13
Zachary W., Fitch M.S., Glenn J.R. Whitman: Incidence, risk, prevention ventilator-associated pneumonia in adult cardiac surgical patients: a systematic review. J. Card. Surg. 2014; 29 (2): 196–203.
(check this in PDF content)
14
Gu W.-J., Wang F., Tang L. et al. Colistin for the treatment of ventilator-associated pneumonia caused by multidrugresistant Gram-negative bacteria: a meta-analysis. Inter. J. Antimicrob. Agents.2014; 44: 477–485.
(check this in PDF content)
15
Dimopolous G., Poulakou G., Pneumatikos I.A. et al. Short vs long-duration antibiotic regimens for ventilator-associated pneumonia: a meta-analysis. Chest. 2013; 144 (6): 1759–1767.
(check this in PDF content)
16
Miller A.E., Punt N., Mouton J.W. Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia.J. Antimicrob. Chemother.2013; 68 (4): 900–906.
(check this in PDF content)
17
Kalil A.C., Klompas M., Haynatzki G., Rupp M.E. Treatment of hospital-acquired pneumonia with linisolid or vancomycin: a meta-analysis. BMJ Open. 2013; 3: e003912.
(check this in PDF content)
18
Jiang H., Tang R.-N., Wang J. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a meta-analysis. Eur .J. Clin. Microb. Infect. Dis.2013, 32: 1121–1128.
(check this in PDF content)
19
Melsen W.G., Rovers M.M., Groenwold R.H. et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet. Infect. Dis. 2013; 13: 665–671.
(check this in PDF content)
20
Silvestri L., Weir I., Gregori D. et al. Effectiveness of oral chlorhexidine on nosocomial pneumonia, causative microorganisms and mortality in critically ill patients: a metaanalysis. Minerva Anestesiol.2014; 80 (7): 805–820.
(check this in PDF content)
21
Nie W., Lit B., Xio Q. β-Lactam / macrolid dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. J. Antimicrob. Chemother. 2014; 69: 1441–1446.
(check this in PDF content)
22
Skalsky K., Yahav D., Lador A. et al. Macrolides vs quinolones for community-acquired pneumonia: a metaanalysis.Clin. Microb. Infect. 2013; 19: 370–378.
(check this in PDF content)
23
Ginsburg A.S., Tinkham L., Riley K. et al. Antibiotic nonsusceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis. Int. J. Antimicrob. Agents.2013; 42 (6): 482–491.
(check this in PDF content)
24
Cheng M., Pan Z.-Y., Yang J., Gao Y.-D. Corticosteroid therapy for severe community-acquired pneumonia: a metaanalysis.Respir. Care.2014; 59 (4): 557–563.
(check this in PDF content)
25
Shafiq M., Mansoor M.S., Khan A.A. et al. Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. J. Hosp. Med. 2013; 8 (2): 68–75.
(check this in PDF content)
26
Confalonieri N., Annane D., Antonaglia C. et al. Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr. Infect. Dis. Repir. 2013; 15: 158–166.
(check this in PDF content)
27
Bo L., Li J., Tao T. et al. Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst. Rev. 2014; 10: CD009066.
(check this in PDF content)
28
Cheng H.-H., Tang T.-T., He Q. et al. Beneficial effects of statins on outcomes in pneumonia: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci.2014; 18 (16): 2294–2305.
(check this in PDF content)
29
Filion K.B., Chateu D., Targownik L.E.et al. Proton pump inhibitors and the risk of hospitalisation for communityЧучалин А.Г. Пневмония: актуальная проблема медицины ХХI века acquired pneumonia: replicated cohort studies with metaanalysis. Gut. 2014, 63: 552–558.
(check this in PDF content)
30
Nie W., Zang Y., Chen J. et al. Angiotensin-converting enzyme I/D polymorphism with pneumonia risk: a metaanalysis.J. Renin-Angiotensin-Aldosterone Syst.2014 (Feb. 4).
(check this in PDF content)
31
Gross A.K., Dunn S.P., Feola D.J. et al. Clopidogrel treatment on the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J. Thromb. Thrombolysis. 2013; 35 (2): 147–154.
(check this in PDF content)
32
Yang M., Yan Y., Yin X. et al. Chest physiotherapy for pneumonia in adults. Cochrane Database Syst. Rev.2013; 2: CD006338.
(check this in PDF content)
33
Hemila H., Louhiala P. Vitamin C for preventing and treating pneumonia.Cochrane Database Syst. Rev. 2013; 8: CD005532.
(check this in PDF content)
34
Chavez M.A., Shams N., Ellingtone L.E. et al. Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir. Res. 2014, 15: 50.
(check this in PDF content)
35
Hu Q.J., Shen Y.C., Jia L.Q. et al. Diagnostic performance of lung ultrasound in the diagnosis of pneumonia a bivariate meta-analysis. Int. J. Clin. Exp. Med. 2014; 7 (1): 115–121. Поступила 28.04.15 УДК 616.24+002
(check this in PDF content)